Adel Galal Zaky

Adel Galal Zaky

Auto-generated profile, based on publicly available information

Adel Galal Zaky

Ophthalmology, Menoufia Faculty of Medicine, ShebinElkom, Egypt

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2023 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
ABAhmed Ibrahim Basiony
Ahmed Ibrahim Basiony
SASherry Nissem Atta
Sherry Nissem Atta
NDNoha Mohamed Dewidar
Noha Mohamed Dewidar
AZAdel Galal Zaky
Adel Galal Zaky
Objective: To assess retinal and choroidal thickness changes in chronic kidney disease (CKD) patients using spectral domain optical coherence tomography (SD-OCT). Background: CKD is a devastating health trouble. The eye and the kidney share similar structural and genetic pathways, so that kidney disease and ocular disease may be closely linked. OCT is a precise, fast method for high-definition scanning of the retina and choroid. Patients and methods: A cross sectional study was conducted at Menoufia University Hospital ophthalmology department on 144 eyes of 72 CKD patients divided into 3 groups according to the stage of CKD as follows: group 1: CKD stage 1–2, with Glomerular Filtration Rate (GFR) > 60 ml/min/1.73m2 group 2: CKD stage 3, GFR 30–59 ml/min/1.73m2 and group 3: CKD stage 4–5, eGFR < 29 ml/min/1.73m2. All patients underwent full ophthalmologic examination followed by OCT assessment of retinal, retinal nerve fiber layer (RNFL) and choroidal thickness. Results: Retinal and choroidal thickness were reduced in group 2 (CKD stage 3) and group 3 (CKD stage 4–5) compared with group 1 (CKD stage 1–2). The reduction was more severe in group 3 than group 2. RNFL thickness did not differ between groups. A thinner retina and choroid were associated with an elevated serum C-reactive protein (CRP) concentration, and greater degrees of proteinuria. Conclusion: Chorioretinal thinning in CKD is associated with a lower eGFR, a higher CRP, and greater proteinuria. Further studies, in a large scale of patients, are needed to detect whether these eye changes reflect the natural history of CKD.

1 September 2016 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
AZAdel Galal Zaky
Adel Galal Zaky
HEHesham Mohamed Fouad Elmazar
Hesham Mohamed Fouad Elmazar
MAMohamed Abd El Aziz
Mohamed Abd El Aziz
Purpose: The purpose of this study was to evaluate the longevity results of modified Hughes procedure in reconstructing large lower eyelid defects. Background: The modified Hughes procedure was used to reconstruct large full-thickness lower eyelid defects. Meanwhile, the functional results indicated that ocular surface health in the treated eyes may be affected. Patients and methods: Noncomparative, case series retrospective study was designed after obtaining the approval of the institutional review board at the Ophthalmology Department, Menoufia University, Egypt, where the results of cases who underwent surgery with the modified Hughes procedure during a 7-year interval were evaluated. Results: Eleven patients (seven males and four females) in the age range 59–77 years (mean age 67±5 years) were identified. The follow-up ranged from 12 months to 48 months. Cosmetic, functional, and postoperative results were analyzed. Conclusion: Despite the favorable cosmetic results of the Hughes tarsoconjunctival flap, the procedure has its own limitations. The results indicated that it does affect the functions and tear film stability in the treated eyes.

21 February 2017 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
AZAdel Galal Zaky
Adel Galal Zaky
SMSameh Saad Mandour
Sameh Saad Mandour
MZMarwa Aly Zaky
Marwa Aly Zaky
AEAsmaa Mohamed Ebrahem
Asmaa Mohamed Ebrahem

3 October 2016 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
HGHammouda Hamdy Ghoraba
Hammouda Hamdy Ghoraba
MHMohamed Amin Heikal
Mohamed Amin Heikal
HMHosam Osman Mansour
Hosam Osman Mansour
HAHaithem Mamon Abdelfattah
Haithem Mamon Abdelfattah
EEEmad Mohamed Elgemai
Emad Mohamed Elgemai
AZAdel Galal Zaky
Adel Galal Zaky
The aim of this study is to report the difference in either anatomical or functional outcome of vitreoretinal intervention in cases of gunshot perforating eye injury if done 2–4 weeks or after the 4th week after the original trauma. Patients were treated with pars plana vitrectomy and silicon oil. Surgeries were performed in the period from February 2011 until the end of December 2014. 253 eyes of 237 patients were reviewed. 46 eyes were excluded. 207 eyes of 197 patients were analyzed. The included eyes were classified based on the timing of vitrectomy in relation to the initial trauma into two groups: 149 eyes (the first group) operated on between the 3rd and the 4th week and 58 eyes (the second group) operated on after the 4th week after the trauma. Following one surgical intervention, in the first group, attached retina was achieved in 93.28% of patients. In the second group, attached retina was achieved in 96.55% of patients. All RD cases could be attached by a second surgery. Visual acuity improved in 81.21% of patients, did not change in 15.43% of patients, and declined in 3.35% of patients. In the second group, visual acuity improved in 81.03% of patients, did not change in 12.06% of patients, and worsened in 6.89% of patients. There was no statistically significant difference between the two groups in either anatomical or functional results. We recommend interfering before the 5th week after the trauma as retinal detachment is encountered more in cases operated on after the 4th week. The visual outcome depends on the site of entry and exit (the route of gunshot).

10 July 2020 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
AZAdel Galal Zaky
Adel Galal Zaky
MKMahmoud Tawfik KhalafAllah
Mahmoud Tawfik KhalafAllah
ASAbdelrahman Elsebaey Sarhan
Abdelrahman Elsebaey Sarhan

1 January 2023 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
MZMarwa Aly Zaky
Marwa Aly Zaky
AZAdel Galal Zaky
Adel Galal Zaky
MEMoataz Fayez Elsawy
Moataz Fayez Elsawy
KSKareem Fatehy Shehata
Kareem Fatehy Shehata
MEMohamed Samy Abd Elaziz
Mohamed Samy Abd Elaziz
Background. Ocular surface disease (OSD) is a multifactorial and highly frequent problem. Inadequate or unstable tear film is the main cause, which leads to visual impairments. One of the primary causes of OSD is meibomian gland dysfunction (MGD), with a prevalence of 3.5 to 70%. The aim of this work was to compare the efficacy of azithromycin topical eye drops versus oral doxycycline in MGD individuals. Methods. This prospective comparative cohort research was carried out on 56 patients of both sexes of any age with symptomatic MGD. Randomly, patients were classified into two equal groups: Group 1 was treated twice daily for 4 weeks with topical azithromycin 1% eye drops, while group 2 received oral doxycycline 100 mg capsules twice daily for 4 weeks. Results. In the 1st follow‐up, there was a significant difference between the studied groups in pain and discomfort degree (P value = 0.024) as group 1 showed a higher number of patients with a mild pain degree (P value = 0.013) while group 2 showed a higher number of patients with a severe pain degree (P value = 0.022). There was an insignificant difference between the studied groups in moderate pain degree and lid margin telangiectasia. Conjunctivitis, frothy discharge, and meniscus floaters were significantly higher in group 2 than in group 1 (P value = 0.013, 0.028, and 0.031, respectively). In group 1, the break‐up time test was significantly higher than in group 2 (P value = 0.023). In the 2nd follow up, in group 2 only meniscus floaters were significantly higher than in group 1 (P value = 0.044), while in group 1 break‐up time test was significantly higher than in group 2 (P value = 0.029). Otherwise, there is no significant difference between both the groups. Conclusions. Meibomian gland dysfunction (MGD) could be treated effectively with oral doxycycline and topical azithromycin by improving symptoms, clinical signs, and stabilization of tear film. Moreover, the topical azithromycin group seemed to be superior over the oral doxycycline group in improving the quality of tear film in the short term, having fewer side effects, more compliance, and better tolerability.